Business Wire | May 18, 2021 04:05PM EDT

Medpace Holdings, Inc. to Present at the Jefferies Virtual Healthcare Conference

May 18, 2021

CINCINNATI--(BUSINESS WIRE)--May 18, 2021--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will present at the following investor conference:

Jefferies Virtual Healthcare Conference Date: Wednesday, June 2, 2021 Presentation: 9:00 a.m. ET Speakers: August Troendle, President & Chief Executive Officer, Jesse Geiger, Chief Financial Officer & Chief Operating Officer, Laboratory Operations, and Kevin Brady, Executive Director of Finance

A live webcast of the presentation will be accessible through the "Investors" section of the Company's website at www.medpace.com and will be available for replay following the event.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,900 people across 40 countries as of March 31, 2021.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006056/en/

CONTACT: Investor Contact: Lauren Morris 513.579.9911 x11994 l.morris@medpace.com

CONTACT: Media Contact: Julie Hopkins 513.579.9911 x12627 j.hopkins@medpace.com